TICKERNERD
Menu
ATRATRHealthcare · Medical Instruments & Supplies

ATR Stock Forecast: AptarGroup, Inc. Price Predictions for 2026-2027

Last close, 9 Sept 2026
$122
−1.79% on the day

The 8 Wall Street analysts covering AptarGroup, Inc. hold a median 12-month price target of $164 — +34.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 49 of 100 as at 8 Sept 2026 — in the lower half.

Market cap
$7.9B
Ticker Nerd rank
49 / 100
Median analyst target
$164
Analysts covering
8
Revenue$982.9M+10.8% y/y
Operating income$108.6M
Net income$72.8M
Free cash flow$52.7M
Quarterly, 7 quarters to 31 Mar 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−6.7%
1M
−9.8%
YTD
+1.3%
1Y
−9.6%
From 52W high
−15.6%
From 52W low
+9.5%
$112
$145
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ATR stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores AptarGroup, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 8 Sept 2026
49 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
91
Quality
90
Revisions
77
Issuance
52
Accruals
43
Growth
41
Momentum
33
Value
25
Size
18

Volatility (91): The share price has been relatively steady.

Value (25): The shares cost a lot relative to the profits and assets behind them.

Size (18): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ATR stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ATR, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$100$120$140$160$180$200$220Oct 25Jan 26Apr 26Jul 26ATRHigh $220Median $164Low $155

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says8 analysts
7 Buy1 Hold0 Sell
Low $155Median $164High $220

The green dot is the last close — the median target sits +34.3% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
3 Aug 2026Wells FargoMaintainsOverweight$145 → $155
4 May 2026Wells FargoMaintainsOverweight—
4 May 2026Wells FargoMaintainsOverweight$144 → $145
20 Mar 2026Wells FargoUpgradeOverweight—
6 Jan 2026Wells FargoDowngradeEqual-Weight—
3 Nov 2025BairdMaintainsOutperform—
3 Nov 2025Wells FargoMaintainsOverweight—
10 Sept 2025Wells FargoMaintainsOverweight—
4 Sept 2025KeybancInitiatesOverweight—
4 Aug 2025Raymond JamesMaintainsOutperform—
4 Aug 2025Wells FargoMaintainsOverweight—
18 July 2025Wells FargoMaintainsOverweight—
15 July 2025Raymond JamesMaintainsOutperform—
6 May 2025Wells FargoMaintainsOverweight—
22 Apr 2025Raymond JamesMaintainsOutperform—
10 Feb 2025BairdMaintainsOutperform—
10 Feb 2025Raymond JamesReiteratesOutperform—
10 Feb 2025Wells FargoMaintainsOverweight—
7 Jan 2025Raymond JamesInitiatesOutperform—
6 Jan 2025Wells FargoMaintainsOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ATR appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

ATR vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 9 Sept 2026, AptarGroup, Inc. returned −9.6% against +18.5% for the S&P 500, dividends included.

ATR vs S&P 500, last 12 monthsTotal return, rebased to 100
8090100110120Oct 25Jan 26Apr 26Jul 26ATRS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ATR analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+0.1%
Analysts raising
3
Analysts cutting
2
Fundamentals

AptarGroup, Inc. (ATR) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
22.4×

Cheaper than 34% of US stocks

Price / sales
2.0×

Cheaper than 53% of US stocks

Price / book
3.0×

Cheaper than 34% of US stocks

EV / EBITDA
11.5×

Cheaper than 33% of US stocks

Growth & margins
Revenue growth (YoY)
6.3%

Higher than 42% of US stocks

Earnings growth (YoY)
−21.6%

Higher than 20% of US stocks

Gross margin
35.8%

Higher than 44% of US stocks

Operating margin
12.5%

Higher than 68% of US stocks

Net margin
9.2%

Higher than 68% of US stocks

Returns & dividend
Return on equity
13.5%

Higher than 71% of US stocks

Return on assets
6.1%

Higher than 82% of US stocks

Dividend yield
1.5%

Higher than 36% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

AptarGroup, Inc. (ATR) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • AptarGroup, Inc. has a market value of $7.9B and an enterprise value of $9.2B.

  • Revenue in the twelve months to 31 Mar 2026: $3.9B. The latest quarter grew 6.3% year on year.

  • Net income over the same four quarters: $386.6M, a 10.0% net margin.

  • Diluted earnings per share, trailing twelve months: $5.84.

  • Free cash flow in the twelve months to 31 Mar 2026: $323.9M, after $279.0M of capital spending.

  • AptarGroup, Inc. spent $385.0M on share buybacks and $121.8M on dividends in the twelve months to 31 Mar 2026.

  • Shares outstanding: 63.6M.

  • Trailing P/E: 22.4×; forward P/E: 19.7× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 1.54%, paying out 34% of earnings.

  • AptarGroup, Inc. employs 14,000 people — $277K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 10 Sept 2026

Data provided by Twelve Data

Peers

ATR vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
ATRAptarGroup, Inc.$7.9B
49
RGENRepligen Corp.$9.5B
93
MMEDMiniMed Group, Inc.$6.5B
2
AVTRAvantor, Inc.$10.4B
80
BLCOBausch + Lomb Corp.$6.3B
87
TFXTeleflex, Inc.$6.1B
81
ALGNAlign Technology, Inc.$11.0B
84

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own AptarGroup, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ATR news & analysis

AptarGroup, Inc. (ATR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Seeking Alpha · 9 Sept 2026neutral

AptarGroup, Inc. presented at the Wells Fargo 21st Annual Healthcare Conference, with a transcript of the presentation published by Seeking Alpha. The presentation covered the company's healthcare segment activities at the investor event.

Why it matters — ATR watchers would care because the presentation offers direct insight into the company's healthcare business and its messaging to investors at a major industry conference.

Dividend Champion, Contender, And Challenger Highlights: Week August 16

Seeking Alpha · 14 Aug 2026neutral

Seeking Alpha published a weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers, covering companies that changed their dividends and those with upcoming ex-dividend dates for the week of August 16.

Why it matters — ATR watchers may monitor this weekly roundup for any changes to AptarGroup's dividend status or upcoming ex-dividend dates relevant to their holdings.

AptarGroup Q2 Earnings Beat Estimates on Pharma & Beverage Growth

Zacks Investment Research · 5 Aug 2026positive

AptarGroup reported Q2 earnings and revenue that beat estimates, driven by growth in its pharma and beverage segments, which helped push quarterly revenues above $1 billion for the first time despite margin pressure.

Why it matters — ATR watchers would note the milestone of surpassing $1 billion in quarterly revenue, showing strong demand in key end markets even as margins face headwinds.

Why AptarGroup (ATR) International Revenue Trends Deserve Your Attention

Zacks Investment Research · 3 Aug 2026neutral

A Zacks Investment Research report examines AptarGroup's international revenue performance and how it influences Wall Street analysts' expectations and the company's future prospects.

Why it matters — For ATR watchers, international revenue trends are a key driver of analyst projections and the company's growth outlook.

AptarGroup, Inc. (ATR) Q2 2026 Earnings Call Transcript

Seeking Alpha · 31 July 2026neutral

AptarGroup published the transcript of its Q2 2026 earnings call on Seeking Alpha.

Why it matters — Earnings call transcripts provide investors with detailed management commentary on quarterly financial results and business outlook.

FAQ

Frequently asked questions about ATR stock

What is the ATR stock price forecast for 2026-2027?

The 8 Wall Street analysts covering AptarGroup, Inc. have a median 12-month price target of $164, with estimates ranging from $155 to $220. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ATR stock a buy right now?

Of the 8 analysts covering AptarGroup, Inc., 7 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks AptarGroup, Inc. 49 out of 100 across roughly 4,600 US stocks as at 8 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ATR?

As at 8 Sept 2026, AptarGroup, Inc. ranks 49 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (91 of 100).

Will ATR stock go up?

No one can know that. What the data says: the median 12-month target from 8 analysts implies +34.3% from the last close, and Ticker Nerd's factor model ranks AptarGroup, Inc. 49 out of 100 as at 8 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ATR stock forecast for 2030?

No analyst covering AptarGroup, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ATR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $155 to $220 over the next 12 months.

How has ATR stock performed over the past year?

AptarGroup, Inc. returned -9.6% over the 12 months to 9 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does AptarGroup, Inc. do?

AptarGroup Inc. is a global packaging and dispensing technology company that designs and manufactures drug delivery systems, consumer product dispensers, sealing solutions, and active packaging.

What is the latest news on ATR?

The most recent item we track (Seeking Alpha, 9 Sept 2026): "AptarGroup, Inc. (ATR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript". AptarGroup, Inc. presented at the Wells Fargo 21st Annual Healthcare Conference, with a transcript of the presentation published by Seeking Alpha. The presentation covered the company's healthcare segment activities at the investor event.

Company

About AptarGroup, Inc.

AptarGroup Inc. is a global packaging and dispensing technology company that designs and manufactures drug delivery systems, consumer product dispensers, sealing solutions, and active packaging. AptarGroup Inc. serves pharmaceutical, consumer health, beauty, personal care, home care, food, and beverage markets with products such as pumps, valves, closures, nasal spray systems, inhalers, and elastomeric components used in injectable and other drug packaging applications. The company also provides active material science and digital health solutions that support product protection, dosing, and delivery performance across healthcare and consumer applications. AptarGroup Inc. operates through focused business segments including Pharma, Beauty, and Closures, positioning it as a key supplier to brands that rely on precise dispensing, protective packaging, and differentiated user experience in highly regulated and consumer-facing markets.

CEO Mr. Stephan B. Tanda · 14,000 employees · United States · https://www.aptar.com